REXIGO (Relugolix 120mg) x 30 Tablets

Uses of Relugolix 120 mg

• Treats advanced prostate cancer.
• Used for hormone-sensitive prostate cancer.
• Lowers testosterone levels in men.
• Sometimes used in hormone-related conditions (in different doses/combination therapy under medical supervision).

Benefits of Relugolix 120 mg

• Rapid and sustained reduction of testosterone.
• Helps slow or control prostate cancer growth.
• Oral alternative to injectable hormone therapies.
• May improve symptoms like bone pain and urinary issues.
• Faster hormonal suppression compared to some traditional treatments.

How does it work?

Relugolix is a GnRH receptor antagonist. It blocks signals from the pituitary gland that stimulate testosterone production in the testes. This quickly reduces testosterone levels, which slows the growth of hormone-dependent prostate cancer cells.

Precautions

• Take exactly as prescribed, once daily.
• Take at the same time every day.
• Do not stop treatment without doctor advice.
• Inform your doctor about heart disease or clotting problems.
• Tell your doctor about all medicines you are taking.
• Monitor for hot flashes, fatigue, or bone loss with long-term use.
• Not recommended during pregnancy.
• Report chest pain, swelling, or severe weakness immediately.

Side Effects

• Hot flashes
• Fatigue
• Diarrhea
• Elevated blood sugar
• Muscle or joint pain

Get Rexigo (Relugolix 120mg) Tablets at affordable prices from our generic pharmacy

We offer Rexigo (Relugolix 120mg) Tablets, an oral targeted therapy used in the treatment of advanced hormone-sensitive prostate cancer by reducing testosterone levels that support cancer growth.

As a trusted pharmaceutical wholesaler, we supply generic oncology medications to patients, hospitals, physicians, clinics, and healthcare centers in markets including Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Palestine, Qatar, Saudi Arabia, the United Arab Emirates, China, Canada, Brazil, Mexico, Russia, Thailand, Malaysia, Singapore, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.